• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Kosteneffektivität der prophylaxe und behandlung von influenza

    Author(s)
    Rychlik, R
    Heinen-Kammerer, T
    Rusche, H
    Piemy, J
    Scuffham, P
    Zollner, Y
    Griffith University Author(s)
    Scuffham, Paul A.
    Year published
    2003
    Metadata
    Show full item record
    Abstract
    A European core model was developed and applied to assess the cost effectiveness of influenza treatment, regarding vaccination programmes, antiviral prophylaxis and antiviral treatment. The groups investigated, over one influenza season, were high risk and elderly patients from England, France and Germany. This publication considers the information for Germany. Methodology: The incremental cost-effectiveness of deaths averted was used as primary endpoints. The analysis was undertaken from the perspective of the health care sector (third party payer). In the model, each intervention (vaccination or antiviral treatment) is ...
    View more >
    A European core model was developed and applied to assess the cost effectiveness of influenza treatment, regarding vaccination programmes, antiviral prophylaxis and antiviral treatment. The groups investigated, over one influenza season, were high risk and elderly patients from England, France and Germany. This publication considers the information for Germany. Methodology: The incremental cost-effectiveness of deaths averted was used as primary endpoints. The analysis was undertaken from the perspective of the health care sector (third party payer). In the model, each intervention (vaccination or antiviral treatment) is compared to the baseline case (without the investigated intervention). A Delphi-panel was integrated in the German study in order to adapt the model specifically for Germany. Results: Incremental cost-effectiveness ratios, for both groups under investigation, proved to be lower with vaccination in comparison to both antiviral treatments (ion channel inhibitors (ICIs) and neuraminidase inhibitors (NIs)). Therefore, it may be concluded that influenza vaccination is the most cost-effective intervention for Germany.
    View less >
    Journal Title
    Deutsche Medizinische Wochenschrift
    Volume
    128
    Issue
    43
    DOI
    https://doi.org/10.1055/s-2003-43100
    Publication URI
    http://hdl.handle.net/10072/27502
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander